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Reply to the Editor:
We thank Drs Stamm and Steinhoff for
their comments. In the field of tissue-
engineered heart valves, the choice between
synthetic and biologic (either allogeneic or
xenogenic) scaffolds is a major concern. As
have many others, we hypothesized that the
best valve replacement remains a heart
valve. Porcine heart valves have been used
for decades in cardiac surgery with good
clinical results, especially in terms of du-
rability in elderly patients. In particular,
hemodynamic behavior of the latest gener-
ation of porcine bioprostheses, the stentless
porcine valves, was found to be similar to
that of native aortic valves.
These scaffolds, however, need preim-
plantation treatment to avoid acute xeno-
genic rejection. Decellularization seems a
promising choice, because it both induces a
decrease of cell-induced acute rejection
and may allow autologous cell recoloniza-
tion. Our study suggests that nonenzymatic
decellularization may be used without in-
ducing mechanical failure of the matrix in
vivo. Previous decellularization procedures,
such as deep osmotic shock (with distilled
water)1 or use of trypsin and ribonuclease,2
have resulted in graft failure.3 Adverse im-
mune reaction was advocated; however, we
observed that a less aggressive decellulariza-
tion procedure did not induce mechanical
failure after 4-month exposure in the sys-
temic arterial strain, suggesting that the de-
cellularization procedure was critical for the
in vivo outcome.
Stamm and coworkers4 used an enzy-
matic decellularization procedure, but they
reinforced the scaffold with a biodegrad-
able polymer coating. Short-terms results
were satisfactory, but little is known about
the long-term behavior of these polymers.
Previous long-term studies on biodegrad-
able scaffolds as heart valve substitutes
have reported fibrosis, retraction, and graft
dysfunction.5
As noted by Stamm and Steinhoff, co-
agulation and complement activation, with
the risk of collagen-induced platelet aggre-
gation early after implantation, are a major
concern with decellularized matrices. We
found no evidence of thrombus formation
on implanted decellularized scaffolds, and
thrombosis occurred only in a nondecellu-
larized xenograft. However, it should be
underlined that in our study all animals
received aspirin therapy (500 mg daily), as
in usual clinical practice with biologic
valves.
Finally, our study suggests that xenogenic
scaffolds decellularized through a nonenzy-
matic procedure do not induce matrix failure
in a sheep model, and interestingly allow
partial recellularization in vivo. Longer im-
plantation studies are mandatory to confirm
these mechanical results. Moreover, because
autologous cell recolonization of these decel-
lularized scaffolds remains only partial, other
strategies to induce complete recolonization
by proper autologous cells are needed.
André Vincentelli, MD, PhD
Francis Juthier, MD
Brigitte Jude, MD, PhD
Institut National de la Santé et de la
Recherche Medicale (Inserm) ERI-9,
Faculté de Médecine
and
Clinique de Chirurgie Cardio-vasculaire
Cardiologic Hospital
Lille, France
References
1. Allaire E, Guettier C, Bruneval P, Plissonnier
D, Michel JB. Cell-free arterial grafts: mor-
phologic characteristics of aortic isografts,
allografts, and xenografts in rats. J Vasc Surg.
1994;19:446-56.
2. O’Brien MF, Goldstein S, Walsh S, Black
KS, Elkins R, Clarke D. The SynerGraft
valve: a new acellular (nonglutaraldehyde-
fixed) tissue heart valve for autologous recel-
lularization first experimental studies before
clinical implantation. Semin Thorac Cardio-
vasc Surg. 1999;11:194-200.
3. Simon P, Kasimir MT, Seebacher G, Weigel
G, Ullrich R, Salzer-Muhar U, et al. Early
failure of the tissue engineered porcine heart
valve SYNERGRAFT in pediatric patients.
Eur J Cardiothorac Surg. 2003;23:1002-6.
4. Stamm C, Khosravi A, Grabow N, Schmohl K,
Treckmann N, Drechsel A, et al. Biomatrix/
polymer composite material for heart valve tis-
sue engineering. Ann Thorac Surg. 2004;78:
2084-92.
5. Vesely I. Heart valve tissue engineering. Circ
Res. 2005;97:743-55.
doi:10.1016/j.jtcvs.2006.05.017
Lung transplantation in a patient
with Mounier-Kuhn syndrome
To the Editor:
We previously reported the first case of
successful lung transplantation in a patient
with Mounier-Kuhn syndrome.1 The pa-
tient was a 59-year-old woman with a his-
tory of bronchiectasis of unknown etiology
since childhood. The patient developed
very severe obstructive lung disease and
multiple episodes of pneumonia due to
Pseudomonas aeruginosa that necessitated
hospitalization. Computed chest tomogra-
phy and bronchoscopy were diagnostic of
Mounier-Kuhn syndrome. The patient un-
derwent bilateral lung transplantation, and
the degree of bronchomegaly was not as
pronounced as the tracheomegaly and posed
little difficulty during transplantation. The
patient had a difficult postoperative course,
with multiple failed extubations, P aerugi-
nosa pneumonia, and prolonged respiratory
failure necessitating tracheostomy. The pa-
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tient was discharged home after making a
successful recovery, followed by inpatient
rehabilitation therapy. Subsequent hospital-
ization for surgical closure of the tracheos-
tomy was followed by pneumonia, the need
for mechanical ventilatory support, and redo
tracheostomy. The prolonged hospitalization
included recurrent pneumonias, malnutrition,
and skin breakdown. Sepsis eventually devel-
oped, and supportive therapy was withdrawn
after discussion with the patient’s family.
Another recent article2 also described
double-lung transplantation for chronic ob-
structive pulmonary disease and bronchiec-
tasis in a patient with Mounier-Kuhn syn-
drome. The patient developed dynamic
airway collapse and required stent place-
ment in both the main bronchi. These cases
highlight the potential dangers of lung
transplantation in patients with Mounier-
Kuhn syndrome. Typically, patients with
bronchiectasis undergo bilateral lung trans-
plantation because of the risk of recurrent
infections. Mounier-Kuhn syndrome is a
very rare cause of bronchiectasis; however,
in immunocompromised patients, it may
pose challenges beyond those posed strictly
as a result of recurrent suppurative infections
of the pulmonary parenchyma. Because of a
lack of longitudinal muscle fibers and thin-
ning of the muscular layer, their central
airways are floppy and widely dilated, with
out-pouchings, allowing for pooling of se-
cretions and persistent colonization with
resistant infections.1,3 This makes recurrent
infections very likely despite the removal
of both lungs. These mechanical abnormal-
ities of the central airways can also compro-
mise secretion clearance as a result of an
ineffective cough.1 In addition, the large
difference in diameter between the central
and peripheral airways and the collapsibil-
ity of central airways on exhalation make
effective mechanical ventilation a chal-
lenging proposition because of poor lami-
nar flow.4 Our patient also exhibited a lack
of spontaneous closure of the tracheostomy
stoma, thus necessitating surgical closure,
which was soon followed by pneumonia.
Although this was not exhibited by our
patient to a significant degree, the other
potential problem in these patients can con-
ceivably be a large disproportion between
the bronchial diameter of the donor and the
recipient, thus making surgery complicated
and compromising subsequent healing of
the anastomosis. Because lung transplanta-
tion has become the standard of care for
managing various advanced lung diseases, it
is important to recognize this unusual cause
of bronchiectasis so as to better inform our
patients of the risk of potential complications.
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